Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 19.80M | £ 31.20M | £ 58.80M | £ 44.20M | £ 9.40M |
Total Assets | £ 838.90M | £ 791.20M | £ 509.10M | £ 383.60M | £ 240.70M |
Total Debt | £ 204.00M | £ 164.50M | £ 120.50M | £ 19.90M | £ 26.60M |
Net Debt | £ 184.20M | £ 133.30M | £ 61.70M | £ -24.30M | £ 17.20M |
Total Liabilities | £ 390.80M | £ 345.20M | £ 242.80M | £ 120.20M | £ 102.50M |
Stockholders Equity | £ 448.10M | £ 446.00M | £ 266.30M | £ 263.40M | £ 138.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |